Daily Stock List
ITUS Corp. (ITUS)
SmallCapVoice reported previously on ITUS Corp. (ITUS), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.
Los Angeles, California-headquartered ITUS Corp. is a company that builds and protects innovation. Founded in 1982, ITUS develops and acquires patented technologies for the purposes of patent monetization and patent assertion. The Company’s management team has greater than three decades of combined experience in Patent Monetization and Patent Assertion. The Company was formerly known as CopyTele, Inc. It changed its corporate name to ITUS Corp. in September 2014. ITUS lists on the OTC Markets Group’s OTCQB.
In essence, ITUS funds, develops, acquires, and licenses emerging technologies. The generation of revenue from patents and patented technologies is Patent Monetization. Patent Assertion is a specialized type of Patent Monetization. This is when a patent owner (or a representative of the patent owner) looks to prohibit or collect royalties from the unauthorized manufacture, sale, and use of a patented invention.
Currently, ITUS has eight patent portfolios in the areas of Key Based Web Conferencing Encryption, Encrypted Cellular Communications, Nano Field Emission Display (nFED), Micro Electro Mechanical Systems Display (MEMS), J-Channel Window Frame Construction, VPN Multicast Communications, Internet Telephonic Gateway, and Enhanced Auction Technologies.
In executing the Company’s business model, ITUS will monetize its existing patent portfolios, as well as acquire additional patents and patent assertion rights from third parties.
ITUS announced this past March that its wholly-owned subsidiary, J-Channel Industries Corp. (JCIC), entered into a settlement agreement with Woodgrain Millwork, Inc. and The Windsor Window Company, Inc. This is in connection with JCIC's patented J-Channel Window Frame Construction technology. The Agreement resolves a patent infringement lawsuit, which will be dismissed.
ITUS’ present areas of interest include High-Technology, Biotechnology, Life Sciences, and Informatics. Current licensing programs involve encrypted communications, and advanced materials. The Company has an ongoing program to develop highly efficient, flat panel displays, based upon a proprietary technology employing carbon Nanotubes and phosphor-luminescence.
ITUS Corp. (ITUS), closed Wednesday's trading session at $0.13, down 7.14%, on 704,250 volume with 74 trades. The average volume for the last 60 days is 135,570 and the stock's 52-week low/high is $0.0555/$0.325.
PEN, Inc. (PENC)
SmallCapVoice and Outcast Traders reported previously on PEN, Inc. (PENC), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
PEN, Inc. is a worldwide leader in developing, commercializing, and marketing enhanced-performance products enabled by nanotechnology. PEN stands for Products Enabled by Nanotechnology. The Company concentrates on innovative and advanced product solutions in safety, health, and sustainability. Products from its family of companies are for healthcare to homecare, homeland defense to food security, and transportation to recreation. PEN has its headquarters in Deerfield Beach, Florida.
The Company is the combination of Nanofilm, Ltd. and Applied Nanotech Holdings, Inc. These are two nanotechnology pioneers. PEN formed to harness the potential of nanotechnology in real-world products for real-world users. With the combination of these two companies, PEN offers nano-layer coatings, nano-based cleaners, and nano-composite products.
Nanofilm was established in 1985 by Mr. Scott Rickert, Chief Executive Officer of PEN. Applied Nanotech Holdings is an international leader in nanotechnology research and development (R&D). It has over 25 years in the industry and holds more than 250 patents.
PEN is developing a new category of cleaning products intended to clean and fortify surfaces at the nanoscale-level. PEN products will incorporate natural elements and sustainable chemistry to keep surfaces safe. PEN’s objective is to transform the $50 billion global market for industrial and institutional cleaning. This consists of lodging, retail outlets, and workplaces. Furthermore, PEN says that the product is suitable for the $80 billion worldwide household cleaning market.
Last month, PEN announced the launch of HALO™. This is the Company’s first-of-its-kind everyday surface care product, a natural mineral protector and fortifier, and a cleaner that works at the nanometer scale to help create a healthy surface. HALO is fast-acting, easy to apply, and creates a healthy surface through purging surfaces of dust and dirt, fortifying hard surfaces with a blanket of continuing protection, and preventing accumulation of harmful debris and contaminants.
HALO penetrates and remains after each application without repeated use of harsh cleaners. After use, HALO is persistent in fortifying the surface to help create a long-lasting safe and healthy environment.
PEN, Inc. (PENC), closed Wednesday's trading session at $0.0361, up 3.44%, on 115,513 volume with 11 trades. The average volume for the last 60 days is 229,508 and the stock's 52-week low/high is $0.0272/$0.1107.
Thinspace Technology, Inc. (THNS)
SmallCapGrowth, KingPennyStocks, PennyStocks24, StockRockandRoll, ResearchOTC, and PennyStockLocks.com reported this month on Thinspace Technology, Inc. (THNS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Thinspace Technology, Inc. is a worldwide provider of reliable, scalable, and affordable application delivery, virtualization, and cloud client technology. The Company provides this technology to public and private sector companies and organizations of all sizes. Its list of private and public sector customers include NASA, PWC, Deutsche Bank, Toyota, and, NHS, local councils, universities, schools, and also housing associations. Thinspace Technology operates in high growth B2B markets of application delivery, virtualization, and cloud client technology. The Company is based in Port Orange, Florida. It also has international offices in the U.K., Canada, and India.
Thinspace Technology offers its Propalms TSE. This is an application delivery solution, which permits windows applications and desktops to be managed centrally and delivered to users on demand, and to any device regardless of location. Propalms TSE enhances Windows® Remote Desktop Services (RDS). It provides an on-demand application delivery platform effectively bridging the gap between native RDS and Citrix.
Additionally, the Company offers its Pano for VDI. The Pano solution includes everything needed to deploy virtual desktops on top of VMware or Microsoft virtualization platforms. In one integrated system, users get a choice of Thinspace’s inventive award-winning Pano zero client, the new Pano Virtual Client for repurposed PCs/Laptops, and Pano Remote for secure remote access from anywhere.
Thinspace Technology’s products also include OneGate. This is an application gateway that provides secure remote access to applications using standards based SSL encryption. Thinspace also offers Universal Client. It provides access to applications or Windows desktops from one’s iPad, iPhone, or Android tablet or Smartphone.
Thinspace Technology announced, in December 2014, the release of its new skyGate support for mobile devices. It skyGate version 4.5 includes exclusive support for smartphones and tablets through providing a mobile friendly portal for users to access the hosted applications and virtual desktops via skyGate.
In March, Thinspace Technology unveiled its newest virtualization solution called skyView. It provides customers and end-users with secure, browser-based access to remote desktops and applications for those working out of the office and on the road. With the Company’s skyView, any HTML5 compatible browser such as Chrome, Firefox, and IE 10 can become the virtual desktop through its HTML5 support feature with no client software or installation required. The only requirement is HTML.
Last month, Thinspace Technology announced the rebrand of its OneGate VPN solution to skyGate SSL VPN alongside the release of skySpace, the Company’s new all-inclusive end-to-end desktop virtualization solution. Thinspace skyGate enables simple, secure remote access to remote desktops and applications.
Thinspace Technology, Inc. (THNS), closed Wednesday's trading session at $0.005, down 28.57%, on 5,451,023 volume with 106 trades. The average volume for the last 60 days is 882,046 and the stock's 52-week low/high is $0.0069/$0.246.
Relmada Therapeutics, Inc. (RLMD)
Penny Stock Bets, StreetAuthority Financial, Investors Alley, Dividend Opportunities, and Trade of the Week reported recently on Relmada Therapeutics, Inc. (RLMD), and we report on the Company, here at the QualityStocks Daily Newsletter.
Relmada Therapeutics, Inc. is a clinical-stage, specialty pharmaceutical company with corporate headquarters in New York City. The Company focuses on developing novel versions of proven drug products in combination with new chemical entities that potentially address areas of high unmet medical need in the treatment of pain. Relmada Therapeutics has a varied portfolio of four lead products at different stages of development. The Company lists on the OTC Markets’ OTCQB.
Relmada’s four lead products are LevoCap ER, d-Methadone, MepiGel, and BuTab ER. LevoCap ER is a proprietary once-a-day extended release dosage form of the opioid analgesic levorphanol. LevoCap ER is in an abuse deterrent drug delivery system. It is a new tamper-resistant, extended release form of levorphanol.
The Company’s d-Methadone is the d optical isomer of racemic methadone and an antagonist at the N-methyl-D-aspartate (NMDA) receptor. In addition, Relmada’s MepiGel is a proprietary topical dosage form of the local anesthetic mepivacaine for the treatment of painful peripheral neuropathies.
Its BuTab ER is a proprietary once-a-day extended release dosage form of oral buprenorphine. It is undergoing development for the treatment of chronic moderate to moderately severe pain and opioid dependence.
Relmada Therapeutics entered into an agreement with Memorial Sloan Kettering Cancer Center (MSKCC) in a series of animal studies for levorphanol, the active ingredient of LevoCap ER. Gavril Pasternak, MD, PhD, of MSKCC is the lead investigator for these studies.
Last week, Relmada Therapeutics announced that it successfully completed a Phase 1 single ascending dose (SAD) clinical study with d-Methadone (dextromethadone, REL-1017). This is its novel, N-methyl-D-aspartate (NMDA) receptor antagonist undergoing development for the treatment of neuropathic pain.
The study results indicate that d-Methadone was generally well tolerated. A maximum tolerated dose (MTD) was attained. The planned multiple ascending dose (MAD) study with d-Methadone will commence in the second half of this year. Assuming successful completion of the MAD study, d-Methadone could enter Phase 2 clinical development in the first half of next year.
Relmada Therapeutics, Inc. (RLMD), closed Wednesday's trading session at $1.57, up 1.29%, on 18,190 volume with 38 trades. The average volume for the last 60 days is 80,643 and the stock's 52-week low/high is $1.50/$4.00.
4Cable TV International, Inc. (CATV)
We are highlighting 4Cable TV International, Inc. (CATV) today, here at the QualityStocks Daily Newsletter.
4Cable TV International, Inc. is a global manufacturer of outdoor transmission equipment for the cable and broadband industry. The Company’s patent-pending innovations offer broadband, phone, and digital/cable TV service providers with cost-effective solutions that maximize bandwidth, extend system penetration, and save energy. 4Cable TV has owned and operated manufacturing and research facilities in Conway, South Carolina since 2005. 4Cable TV International lists on the OTC Markets’ OTCQB.
4Cable TV offers the cable TV industry a 50 percent decrease in current (power) requirements with fundamentally the same operational specifications. The Company has developed proprietary circuitry, which allows a low current 1 GHz CATV amplifier to be constructed. Its flagship product lines are the DSR No Diplexer Node, the RF2F Cable TV Network Extension System, and the PowerMiser™ amplifier.
Concerning power saving CATV distribution amplifiers, the PowerMiser™ Line extender with equivalent RF gain and output levels will draw approximately 410 mA and maintain distortions in the mid to low 70s range. Current CATV 1 GHz line extenders draw around 850 mA of current and have distortions in the mid to low 70s.
In addition to considerable power savings, other advantages of the 4Cable TV PowerMiser™ products include higher reliability due to lower heat generated by the amplifier; longer operation of standby power supplies; and less voltage drop in the cable resulting in fewer power supplies required.
4Cable TV International announced in October 2014 that a top-five Cable Multi-System Operator (MSO) successfully concluded lab and field trials of the Company's patent-pending RF2F technology. The results of the lab and field trials open the way for the purchase and deployment of RF2F to the MSO's cable systems throughout the nation. The trials demonstrated in field settings the successful commercial application of RF2F to extend the cable operator's network coverage.
Some of the 2014 highlights for 4Cable TV International include the Company expanding its patent-pending RF2F™ product offerings from five devices to over a dozen different styles and configurations. The Company also signed contracts with five Independent U.S. Sales Representative firms, one Canadian distributor, and one European distributor. This added 20 sales personnel to its sales team.
4Cable TV International, Inc. (CATV), closed Wednesday's trading session at $0.01, down 0.99%, on 1,972,800 volume with 28 trades. The average volume for the last 60 days is 136,590 and the stock's 52-week low/high is $0.0075/$0.23.
One World Holdings, Inc. (OWOO)
The QualityStocks Daily Newsletter would like to spotlight One World Holdings, Inc. (OWOO). Today, One World Holdings, Inc. closed trading at $0.0034, off by 15.00%, on 53,296,018 volume with 383 trades. The stock’s average daily volume over the past 60 days is 3,427,114, and its 52-week low/high is $0.0008/$0.05.
One World Holdings, Inc. subsidiary, The One World Doll Project, announced today that it has released an interview with its Founder, Trent T. Daniel in which he discusses the company's recent national retail distribution deal with Hallmark stores and Walmart. This interview will give our shareholders, potential investors and others the opportunity to understand the details behind our Fall 2015 debut in over 2,900 Walmart stores across the nation, stated Mr. Daniel.
One World Holdings, Inc. (OWOO) subsidiary, The One World Doll Project, was established in 2010 to make a significant positive cultural impact through the doll category, transcending global and ethnic borders to create positive self-image in young women and girl around the world. Led by worldwide famous doll designer Stacy McBride-Irby, The One World Doll Project team has more than 50 collective years in the doll and toy industry and is dedicated and armed with the experience to ensure that the dolls are of the highest quality and value.
In 2013, the company released its Prettie Girls!™ line of multi-cultural fashion dolls uniquely designed with individual physical attributes, personal stories and hobbies, and goals and inspirations. For young girls, the dolls are a friend, a partner in play, and a glimpse of their biggest, brightest dreams. For young women, the dolls are a symbol of who they are and what they can achieve. For doll connoisseurs, The One World Doll Project promises stylish works of art that will become a vital part of a growing collectors’ market.
The One World Doll Project also has a Signature Celebrity Collection of Prettie Girls! and in 2013 released its first celebrity collectors doll modeled after supermodel Cynthia Bailey from The Real Housewives of Atlanta. Since the release of the doll, it has been showcased with Synthia on The Arsenio Hall Show, What Happens Live with Andy Cohen and The Bethenny Show.
Using a web-based sales model, One World Holdings plans to quickly capture significant market share in the dolls and stuffed toys space. After securing a strong online presence, the company will focus on brick and mortar retailing as it moves toward the ultimate pursuit of expanding worldwide. The company has established distribution deals with Toys “R” Us, HEB, dollgenie.com, Tuckers Toy Shop, pattycakedoll.com, and has recently expanded its retail presence internationally with the People’s Pharmacy storechain in the Central American country of Belize. The Prettie Girls! Dolls have been featured in national and international media spotlights like CNN, The Wall Street Journal, Jet Magazine, Bloomberg.com, Parade.com, Dolls Magazine, The Toy Book, The Houston Chronicle and Houston Business Journal, and TheStreet.com. Disclaimer
One World Holdings, Inc. Company Blog
One World Holdings, Inc. News:
Walmart Deal Secured; The One World Doll Project Founder Interviews With CEOLIVE.TV
The One World Doll Project To Launch New Prettie Girls!™ Tween Scene Collection At Walmart In October 2015
One World Holdings Announces Yearly Revenue Increase of 532%
Well Power Inc. (WPWR)
The QualityStocks Daily Newsletter would like to spotlight Well Power Inc. (WPWR). Today, Well Power Inc. closed trading at $0.0011, up 22.22%, on 73,509,695 volume with 59 trades. The stock’s average daily volume over the past 60 days is 7,137,814, and its 52-week low/high is $0.0005/$0.1395.
Well Power Inc. (WPWR) has secured the licensing rights to Texas with the first right of refusal on the other US states to a new technology solution to process waste natural gas, such as vented, flared or stranded gas, into “clean power” and engineered fuels, including no-sulphur diesel and diluents. Based on proprietary technology, this solution is mobile, high-yield and can be deployed with minimum capital expenditure.
The company plans to be able to provide its technology with full-service engineering, design, construction, modular fabrication, maintenance and construction management services to clients in the upstream areas of exploration and production. Well Power will also offer consulting services, process assessments, facility appraisals, feasibility studies, technology evaluations, project finance structuring and support, and multi-client subscription services.
Approximately 2.4 million barrels of oil equivalent is wasted each day by gas flaring alone, resulting in $10 billion of lost revenue and 400 million metric tons of CO2 equivalent global greenhouse gas emissions each year. Additionally, environmental degradation associated with gas flaring has been shown to have a significant impact on local populations, often resulting in loss of livelihood and severe health issues.
Well Power’s Micro Refinery Unit (MRU) offers the opportunity to create value from a wasted resource while simultaneously enabling wider access to energy, improved environmental conditions, and economic development for local populations. By eliminating legacy flaring and minimizing new flaring, the company is well positioned to take a leadership role in the ongoing push for sustainable resource development and energy efficiency. Disclaimer
Well Power Inc. Company Blog
Well Power Inc. News:
Well Power Inc. Appoints Professional Engineer, Oil & Gas Veteran to Board of Directors
Well Power - Letter from President to Shareholders
Well Power Inc. to host second webinar on proprietory micro-refinery technology
Growblox Sciences, Inc. (GBLX)
The QualityStocks Daily Newsletter would like to spotlight Growblox Sciences, Inc. (GBLX). Today, Growblox Sciences, Inc. closed trading at $0.52, up 10.64%, on 174,777 volume with 96 trades. The stock’s average daily volume over the past 60 days is 65,237, and its 52-week low/high is $0.151/$1.65.
Growblox Sciences, Inc. (GBLX), a biopharmaceutical research and development company, is focused on creating safe, standardized pharmaceutical-grade cannabis-based therapies for various medical conditions. The company is pioneering technology, industry-leading processes, and a big data-driven clinical research and development algorithm to bring relief to patients in communities across the country.
The company’s GrowBLOX technology suite includes the TissueBLOX, GrowBLOX, and CureBLOX equipment. Together, these components provide unparalleled control and monitoring of cannabis cultivation throughout the plant's life-cycle. These patent pending processes were designed to produce a safe and consistent cannabis product under cGMP guidelines. Utilizing a computer-regulated system that optimizes the nutrients, water, temperature, and gas levels, the GrowBLOX suite produces cannabis with more active ingredients per pound than traditional cultivation methods.
Also, based on an analysis of preclinical and clinical data from thousands of peer-reviewed studies, Growblox Sciences has identified the most effective profiles of cannabinoids and terpenes for the treatment of conditions within seven therapeutic categories. As a result of this extensive research and the analysis of the active ingredient profiles of 30,000 Cannabis strains in conjunction with a major testing lab, the company will be able to provide patients with natural cannabis strains containing the ideal ratios for treating specific diseases or symptoms.
Another significant advantage held by the company stems from an accelerated drug development program to finish in 3-5 years instead of the 15-20 years typically seen in traditional pharmaceutical development programs. Armed with an intellectual property strategy that takes full advantage of the design of the GrowBLOX technology suite and protects the valuable foundation laid, Growblox Sciences has positioned itself well for long-term success in the burgeoning cannabis space. Disclaimer
Growblox Sciences, Inc. Company Blog
Growblox Sciences, Inc. News:
GrowBLOX Receives Funding to Complete Construction of Nevada Cultivation Facility
GrowBLOX Announces Deployment of Commercial Units
Growblox Sciences, Inc. (GBLX) is “One to Watch”
Car Monkeys Group (CKMY)
The QualityStocks Daily Newsletter would like to spotlight Car Monkeys Group (CKMY). Today, Car Monkeys Group closed trading at $0.142, up 4.57%, on 10,500 volume with 4 trades. The stock’s average daily volume over the past 60 days is 7,628, and its 52-week low/high is $0.05/$3.00.
Car Monkeys Group (CKMY), via CarMonkeys.com, is one of the largest and fastest growing online cars, vans and SUV parts distributors in the United States. Founded in 2010, the Wyckoff, New Jersey-based company formerly was known as Delaine Corporation and changed its name to Car Monkeys Group in February 2015.
With access to hundreds of thousands of parts, Car Monkeys sells used, high-quality, low-mileage automotive parts to consumers, retailers, truck and car fleet owners and auto repair facilities looking for a wide range of vehicle makes and models. Customers have access to a Part Finder section that helps them easily navigate and quickly locate the right parts they need.
Striving to provide customers a quick, hassle-free and convenient shopping experience, all parts ordered through CarMonkeys.com ship from one of the company’s numerous distributors and auto dismantling centers straight to the customer or their mechanic. Advantages such as a five-year unlimited mileage warranty, zero shipping costs, and a generous return policy further contribute to the increasing popularity of the Car Monkeys brand.
Automotive recycling plays a substantial role in the preservation of natural resources and reduction of demand for landfill space. According to the Automotive Recyclers Association, approximately 95% of vehicles retired from use are processed for recycling, saving an estimated 85 million barrels of oil that would have been used to manufacture new or replacement parts. As a rapidly growing and trusted automotive recycling company, Car Monkeys is positioned as a leading player in the broader $22 billion North American automotive recycling industry. Disclaimer
Car Monkeys Group Company Blog
Car Monkeys Group News:
Car Monkeys Group (CKMY) Announces Engagement of QualityStocks Investor Relations Services
Car Monkeys Group (CKMY) is “One to Watch”
Car Monkeys Group (CKMY) Continues Growth as one of the Country’s Largest Online Automobile Parts Distributors
MIT Holding (MITD)
The QualityStocks Daily Newsletter would like to spotlight MIT Holding (MITD). Today, MIT Holding closed trading at $0.03, even for the day. The stock’s average daily volume over the past 60 days is 7,909, and its 52-week low/high is $0.03/$0.29.
MIT Holding (MITD), through its agents, facilitators and contractual obligations, offers professional outpatient medical care with ambulatory infusion therapies, home infusion services, and medical equipment delivery. The company is also pursuing government contacts to obtain approval to import pharmaceutical products into the Americas.
In support of these core services, MIT Holding provides expert legal, accounting, advisory and educational services to physicians, medical centers, hospitals, small and large businesses regarding the Affordable Care Act; offers travel and transportation services of medically challenged patients for medical needs and personal travel; and through its contracts is approved to, conduct and administer FDA clinical trials.
Collectively, these services contribute to MIT Holding’s strategy to provide custom prescription solutions in a variety of methods and generate multiple revenue streams. Following a successful reorganization initiative in January, 2014, MIT Holding is positioned to achieve 32% minimum net profits and has maintained profitability in its fiscal second and third quarters. This profitability validates the company’s business model and its approach to the evolving Affordable Health Care Act and its impact on the health services industry.
MIT Holding meets and/or exceeds major U.S. health insurance requirements and is therefore able to direct bill and receive payments from carriers on behalf of the patient its agents and its facilitators. This ability marks an important step in the company’s goal of developing the first-of-its-kind seamless transition for patient needs from hospital discharge to complete home recovery. This and other corporate initiatives are spearheaded by a management team committed to building shareholder value, revenues and corporate expansion while providing viable solutions to the perpetual changes in the health care sector. Disclaimer
MIT Holding Company Blog
MIT Holding News:
MIT Holding Achieves Positive Net Income From Operations in 2014
MIT Holding (MITD) Launches New Website with Investor Relations Suite
MIT Holding, Inc. Names Tommy J. Duncan as President
Today's Top 3
Wall Street Resources
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Car Monkeys Group (CKMY) Announces Engagement of QualityStocks Investor Relations Services
- Cleartronic, Inc. (CLRI) Subsidiary Signs Agreement With Edmonton International Airport
- Consorteum Holdings, Inc. (CSRH) Signs License Agreement With NYG Holdings
- Dominovas Energy Corp. (DNRG) Enters Second Power Provider Agreement in the Democratic Republic of the Congo
- Galenfeha, Inc. (GLFH) Broadens Oil and Gas Industry Penetration
- Growblox Sciences, Inc. (GBLX) Receives Funding to Complete Construction of Nevada Cultivation Facility
- IFAN Financial, Inc. (IFAN) $2.5 Million Sea Otter Global Ventures Financing Progresses
- International Stem Cell Corp. (ISCO) to Present at International Society for Cellular Therapy Annual Meeting
- Loans4Less.com Inc. (LFLS) Enters into an Acquisition Agreement with 321LEND
- MIT Holding, Inc. (MITD) Launches New Website with Investor Relations Suite
- Mobile Lads Corp. (MOBO) Begins Operating And Buys Control Of North American Shopping Network Simbadeals.com From DoMark International
- One World Holdings, Inc. (OWOO) Walmart Deal Secured; The One World Doll Project Founder Interviews With CEOLIVE.TV
- Pure Hospitality Solutions, Inc. (PNOW) Releases Oveedia Site Snapshots
- Save The World Air, Inc. (ZERO) Deploys Joule Heat Direct Heating System on Gathering Line for Crude Oil Pipeline in Uintah Basin
- View Systems, Inc. (VSYM) Files for Patent, Begins Manufacturing of Enhanced ViewScan Product
- VistaGen Therapeutics, Inc. (VSTA) and NIH Sign Agreement for NIH-Sponsored Phase 2 Study of Orally-Active AV-101 in Major Depressive Disorder
- Well Power Inc. (WPWR) Appoints Professional Engineer, Oil & Gas Veteran to Board of Directors